How Mounjaro affects anticoagulant therapy
No direct interactions have been reported between tirzepatide (the drug in Mounjaro) and common anticoagulants.2
The indirect effects that matter come through three mechanisms:
1. Weight loss: as you lose weight on Mounjaro, your body’s handling of anticoagulants may change, potentially requiring dose adjustments.
2. Reduced food intake: Mounjaro often reduces appetite, which can affect vitamin K intake and absorption of certain anticoagulants.
3. Delayed gastric emptying: Mounjaro slows down digestion, which might alter how quickly some anticoagulants are absorbed.
Clinical anticoagulation guidelines suggest that significant weight changes can affect anticoagulant dosing requirements, particularly for medications dosed by body weight.2
NICE doesn’t specifically contraindicate combining GLP-1 medications with anticoagulants, but standard practice recommends increased monitoring when adding any new medication to an anticoagulant regimen.
Different types of anticoagulants
Anticoagulants fall into several categories, each with different considerations when taking Mounjaro.
Direct oral anticoagulants (DOACs) like apixaban (Eliquis) and rivaroxaban (Xarelto) are commonly prescribed in the UK for atrial fibrillation, deep vein thrombosis, and pulmonary embolism. These medications have fewer food interactions than warfarin but are more directly affected by weight changes.
Vitamin K antagonists like warfarin require stable vitamin K intake for consistent anticoagulation. Since Mounjaro affects eating patterns and potentially vitamin K consumption through green vegetables, INR (a measure of how quickly your blood clots) monitoring becomes particularly important.
Injectable anticoagulants like enoxaparin (Clexane) are less commonly affected by dietary changes but may still require dose adjustments with significant weight loss.
Apixaban-specific guidance when taking Mounjaro
Apixaban (Eliquis) is one of the most commonly prescribed DOACs in the UK. It’s typically dosed based partly on your weight, age, and kidney function.
As Mounjaro leads to weight loss, your dosing requirements may change. Clinical guidelines recommend reassessing your apixaban dosing if significant weight changes occur.2
Apixaban’s absorption is minimally affected by food. This means Mounjaro’s impact on appetite and eating patterns usually doesn’t significantly affect how well apixaban works. It’s somewhat more stable than warfarin when your eating habits change.
The standard dose for most patients is 5mg twice a day, but your doctor might recommend a lower 2.5mg twice a day dose if you:
- Are over 80 years old
- Have reduced kidney function
- Weigh less than 60kg
As you lose weight on Mounjaro, you may cross this 60kg threshold, potentially requiring a dose adjustment. This is why regular weight monitoring matters.
Rivaroxaban-specific guidance when taking Mounjaro
Rivaroxaban (Xarelto) is another commonly prescribed DOAC in the UK with some unique considerations when taking Mounjaro.
Unlike apixaban, rivaroxaban is usually taken once a day and needs to be taken with food to maximise absorption. Since Mounjaro can reduce appetite and meal sizes, it’s essential to take rivaroxaban with a meal.
According to rivaroxaban’s prescribing information, food affects its absorption by approximately 39%. Even a small meal or substantial snack is sufficient for proper absorption.
Rivaroxaban is eliminated through both the kidneys and the liver. As you lose weight on Mounjaro, both kidney function and liver enzyme activity may change slightly, potentially affecting rivaroxaban levels in your body.
The standard rivaroxaban dose for atrial fibrillation is 20mg once a day with food, or 15mg for those with reduced kidney function.
Unlike apixaban, rivaroxaban doesn’t have a specific weight-based threshold for dose adjustment in its licensing. However, significant weight loss may still warrant a review of your dose.
Warfarin-specific guidance when taking Mounjaro
Warfarin requires more careful management alongside Mounjaro than the DOACs. It’s highly sensitive to changes in vitamin K intake, which can shift when appetite decreases on Mounjaro.
Your anticoagulation service will likely recommend more frequent INR checks after starting Mounjaro. This is standard practice when adding any new medication to warfarin therapy.
Reduced food intake on Mounjaro can lower your vitamin K consumption, which may cause your INR to rise and increase bleeding risk. The key point is consistency: you don’t need to avoid vitamin K, but you do need to eat similar amounts of green vegetables each day.
If you find your appetite decreasing significantly, speak to your anticoagulation nurse or GP. They can adjust your warfarin dose based on your changing INR readings.
Monitoring your treatment
When taking both Mounjaro and anticoagulants, appropriate monitoring is important for safety.
Before starting Mounjaro
Your doctor would typically check:
- Current weight and BMI for future comparison
- Kidney function tests, as this affects both medications
- For warfarin patients, a current INR reading
These checks are standard when adding any new medication to an anticoagulant regimen.
Ongoing monitoring
The frequency of monitoring will depend on your specific situation and your doctor’s clinical judgement.
For warfarin patients: your anticoagulation service may recommend more frequent INR checks initially. The specific frequency is determined by your clinician based on your individual risk factors.
For DOAC patients (apixaban or rivaroxaban): DOACs generally don’t require routine blood monitoring, but your doctor may recommend periodic kidney function tests if you experience significant weight loss.
There are no formal UK guidelines specifying exact monitoring schedules specifically for patients taking GLP-1 medications with anticoagulants. Your doctor will determine the appropriate plan based on your individual circumstances.
Signs that need immediate attention
While taking Mounjaro with anticoagulants, use the British Heart Foundation’s ‘RED’ approach to self-monitoring:
- Recent bleeding that’s unusual or prolonged
- Excessive bruising appearing without injury
- Dark stools or red/pink urine
Contact your healthcare provider immediately if you notice any of these signs. Also seek attention for severe headache of sudden onset, significant nausea preventing medication intake, or rapid weight loss exceeding 1 to 2kg per week.
Eating well while taking Mounjaro and anticoagulants
Even when your appetite decreases on Mounjaro, eating three balanced meals a day matters. Consistent nutrition helps your anticoagulant work predictably and supports your overall health during weight loss.
Protein at every meal
Protein helps preserve muscle mass during weight loss, which is particularly important when you’re losing weight on Mounjaro. Aim to include a portion of protein at each meal.
Good sources include eggs, fish, chicken, turkey, lean red meat, Greek yoghurt, beans, lentils, and tofu.
Complex carbohydrates for sustained energy
Complex carbohydrates are rich in fibre, which supports digestion and helps you feel fuller for longer. Include a quarter of your plate as complex carbohydrates at each meal.
Good options from Second Nature’s food lists include wholegrain or sourdough bread, rolled oats, brown rice, potato, sweet potato, quinoa, beans and lentils, and wholemeal pasta.
Healthy fats from whole foods
Fats help your body absorb certain vitamins and keep you satisfied between meals. Choose whole food sources rather than processed options.
Olive oil, avocados, nuts, seeds, and oily fish like salmon and mackerel are all good choices. For rivaroxaban patients, including some fat at each meal also supports proper drug absorption.
Vegetables and the balanced plate
Aim for half your plate to be vegetables at each main meal. This follows Second Nature’s balanced plate model: half vegetables, a quarter protein, a quarter complex carbohydrates, plus a serving of fat.
Vegetables provide essential vitamins, minerals, and fibre. Even when your appetite is reduced, try to include some vegetables at every meal.
Vitamin K consistency for warfarin patients
If you’re on warfarin, you don’t need to avoid vitamin K. The important thing is to eat a consistent amount of green vegetables each day, rather than having large amounts one day and none the next.
Good sources of vitamin K include broccoli, spinach, kale, Brussels sprouts, and green beans. Pick the ones you enjoy and include similar portions regularly.
If Mounjaro reduces your appetite and you’re eating fewer vegetables than usual, let your anticoagulation nurse know. They can adjust your warfarin dose accordingly.
Staying active safely on anticoagulants
Regular movement supports weight loss, improves cardiovascular health, and helps maintain muscle mass while taking Mounjaro. For people on anticoagulants, some extra considerations apply.
Research suggests it takes an average of 66 days to build a new habit.3 Starting small and linking activity to an existing routine, like a 10-minute walk after dinner, is more effective than setting ambitious targets from day one.
Both aerobic activity (walking, cycling, swimming) and resistance training (bodyweight exercises, resistance bands, light weights) offer benefits. Resistance training is particularly helpful for preserving muscle during weight loss on Mounjaro.
Gradually do a little more as it feels manageable. The NHS recommends 150 minutes of moderate activity per week as a longer-term goal, but any movement is better than none.
Activities to approach with caution
If you’re on anticoagulants, it’s sensible to avoid contact sports and activities with a high risk of falls or impact injuries. A bleed from a collision or fall can be more serious when your blood takes longer to clot.
Activities like rugby, boxing, martial arts, and downhill skiing carry higher risk. Walking, swimming, cycling, yoga, and resistance training with appropriate technique are generally safe options to discuss with your GP.
Mounjaro clinical data
The table below summarises key clinical data from Mounjaro’s SURMOUNT trial programme.
| Outcome |
Result |
Source |
| Maximum weight loss (15mg dose) |
Up to 26% after two years |
SURMOUNT-41 |
| Weight regain after stopping |
Participants regained approximately half the lost weight within one year of stopping |
SURMOUNT-41 |
| Drug class |
Dual GIP/GLP-1 receptor agonist |
MHRA |
| Administration |
Subcutaneous injection, once a week |
EMC SmPC |
| Known interaction with anticoagulants |
No direct drug-to-drug interactions identified |
Calvarysky et al. (2024)2 |
| Common side effects |
Nausea, diarrhoea, reduced appetite (most common in early weeks) |
EMC SmPC |
Common questions about Mounjaro and anticoagulants
Does Mounjaro directly interact with anticoagulants?
No. There are no known direct chemical interactions between tirzepatide and common anticoagulants like apixaban or rivaroxaban.2 The considerations are related to how weight loss and reduced food intake might affect your anticoagulant therapy.
Will I need to change my anticoagulant dose on Mounjaro?
Possibly, but not everyone does. The likelihood of needing a dose adjustment increases with greater weight loss. This is particularly relevant if you lose more than 10% of your starting body weight or experience significant changes in eating patterns.
Which anticoagulant is safest with Mounjaro?
Research hasn’t definitively identified one anticoagulant as ‘safest’ with Mounjaro. DOACs like apixaban and rivaroxaban generally require fewer adjustments than warfarin as eating patterns change. Your haematologist or GP can advise on your individual situation.
How quickly will weight loss affect my anticoagulant requirements?
This varies between individuals, but significant changes typically occur after losing 5% to 10% of your starting weight. For most people on Mounjaro, this might happen within the first 2 to 4 months of treatment. The effect is gradual, which is why regular monitoring allows for timely adjustments.
Should I take any special precautions while on both medications?
Yes. Carry medical ID indicating you take both an anticoagulant and Mounjaro. Inform all healthcare providers, including dentists, about both medications. Consider using an electric razor rather than blade razors to reduce bleeding risk. Maintain good hydration, as dehydration concentrates anticoagulants in your bloodstream.
Can I still have medical procedures while on both medications?
Yes, but they require planning. For minor procedures, your doctor might recommend continuing both medications. For major procedures, you might need to temporarily pause one or both. Discuss planned procedures with your healthcare team at least 1 to 2 weeks in advance.
Do I need to avoid any foods while on both medications?
If you’re on a DOAC like apixaban or rivaroxaban, there are no specific foods to avoid. For rivaroxaban, taking it with a meal helps absorption. If you’re on warfarin, the key is consistency with green vegetables rather than avoidance. Eat similar amounts of vitamin K-rich foods each day.
What exercise is safe while taking anticoagulants and Mounjaro?
Most forms of exercise are safe and encouraged. Walking, swimming, cycling, yoga, and resistance training are all good options. Avoid contact sports and high-impact activities where falls or collisions are likely.
Bleeding from injuries can be more serious on anticoagulants. Speak to your GP if you’re unsure about a specific activity.
Take home message
You can take Mounjaro while on anticoagulants like apixaban or rivaroxaban, but proper monitoring and communication with your healthcare team are essential.
The main considerations aren’t direct drug interactions but rather how Mounjaro’s weight loss effects and impact on eating patterns might affect your anticoagulant therapy.
With appropriate monitoring, particularly during the first few months, the combination can be managed safely for most patients. Eating three balanced meals a day helps keep your anticoagulant working predictably.
If you’re managing multiple medications and noticing changes in your mood or stress levels, mention this to your GP. Coordinating several treatments can feel overwhelming, and your healthcare team can help.
If you’re currently taking anticoagulants and considering Mounjaro, ensure your GP, anticoagulation service, and Mounjaro provider are aware of all your medications.
How can Second Nature help?
Second Nature is a digital health programme that combines medication with habit-based support from registered dietitians and coaches.
A 2025 study published in JMIR Formative Research found that active subscribers lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving 10% or more weight loss.4
Second Nature’s approach is built around the balanced plate model: half vegetables, a quarter protein, a quarter complex carbohydrates, plus a serving of fat. The programme has worked with the NHS for over six years as a lead digital provider for the UK’s two largest NHS weight-loss programmes.
Second Nature's Mounjaro and Wegovy programmes
Second Nature provides Mounjaro or Wegovy as part of our Mounjaro and Wegovy weight-loss programmes.
Why choose Second Nature over other medication providers, assuming you're eligible?
Because peace of mind matters.
We've had the privilege of working with the NHS for over eight years, helping people across the UK take meaningful steps toward a healthier, happier life.
Our programmes are designed to meet people where they are, whether that means support with weight loss through compassionate one-to-one health coaching, or access to the latest weight-loss medications (like Mounjaro and Wegovy) delivered alongside expert care from a multidisciplinary team of doctors, psychologists, dietitians, and personal trainers.
At the heart of everything we do is a simple belief: real, lasting change comes from building better habits, not relying on quick fixes. We're here to support that change every step of the way.
With over a decade of experience, thousands of lives changed, and a long-standing record of delivering programmes used by the NHS, we believe we're the UK's most trusted weight-loss programme.
We hope to offer you something invaluable: peace of mind, and the support you need to take that first step.
References
- Aronne, L.J. et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38-48.
- Calvarysky et al. (2024). Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug Safety, 47(5), 439-450.
- Lally, P. et al. (2010). How are habits formed: Modelling habit formation in the real world. European Journal of Social Psychology, 40(6), 998-1009.
- Richards, R. et al. (2025). A remotely delivered GLP-1RA-supported specialist weight management program in adults living with obesity: retrospective service evaluation. JMIR Formative Research, 9(1), e72577.
